Clinical Trial Update: Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating decitabine followed by a cancer antigen vaccine in neuroblastoma and various sarcomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma
• Synovial Sarcoma

Drugs mentioned

• Cancer antigen vaccine (Cancer antigen vaccine)
• Dacogen (decitabine)

Snippet

Sponsor: University of Louisville | Conditions: Neuroblastoma, Ewings Sarcoma | Phase 1 | Status: COMPLETED